Eric Hsu
2021
In 2021, Eric Hsu earned a total compensation of $398.1K as Senior Vice President, PreClinical R&D at InMed Pharmaceuticals.
Compensation breakdown
Bonus | $84,659 |
---|---|
Option Awards | $69,083 |
Salary | $244,327 |
Total | $398,069 |
Hsu received $244.3K in salary, accounting for 61% of the total pay in 2021.
Hsu also received $84.7K in bonus and $69.1K in option awards.
Rankings
In 2021, Eric Hsu's compensation ranked 11,169th out of 12,406 executives tracked by ExecPay. In other words, Hsu earned more than 10.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,169 | 10th |
Manufacturing | 4,927 | 10th |
Chemicals And Allied Products | 2,194 | 7th |
Drugs | 1,952 | 7th |
Pharmaceutical Preparations | 1,442 | 6th |
Hsu's colleagues
We found three more compensation records of executives who worked with Eric Hsu at InMed Pharmaceuticals in 2021.
News
InMed Pharmaceuticals CEO Eric Adams' 2024 pay rises 13% to $415K
October 28, 2024
InMed Pharmaceuticals CEO Eric Adams' 2023 pay falls 22% to $368K
October 27, 2023
InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
October 28, 2022
InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
October 28, 2021